IM Cannabis (IMCC) Operating Expenses (2020 - 2026)
IM Cannabis' (IMCC) quarterly Operating Expenses came in at $2.3 million in Q1 2026, down 1.57% year-on-year from $2.3 million in Q1 2025, and down 82.7% quarter-over-quarter from $13.0 million in Q4 2025.
IM Cannabis (IMCC) Operating Expenses (2020 - 2026) Analysis & Trends
IM Cannabis' Operating Expenses history runs 7 years deep, the most recent figure standing at $2.3 million for Q1 2026.
- On a quarterly basis, Operating Expenses fell 1.57% year-over-year to $2.3 million in Q1 2026; TTM through Mar 2026 was $17.5 million, a 5.01% increase from a year earlier, with the FY2025 full-year figure at $15.3 million, up 11.78% from the prior year.
- Operating Expenses eased to $2.3 million in Q1 2026 per IMCC's latest filing, from $13.0 million in the prior quarter.
- Across five years, Operating Expenses topped out at $13.0 million in Q4 2025 and bottomed at -$13891.7 in Q2 2024.
- The 5-year median for Operating Expenses is $4.6 million (2023), against an average of $5.4 million.
- Biggest YoY gain for Operating Expenses was 158.83% in 2024; the steepest drop was 100.36% in 2024.
- Year by year, Operating Expenses stood at $9.8 million in 2022, then plunged by 55.02% to $4.4 million in 2023, then soared by 158.83% to $11.4 million in 2024, then gained by 14.28% to $13.0 million in 2025, then tumbled by 82.7% to $2.3 million in 2026.
- Per Business Quant, the three latest IMCC Operating Expenses figures stand at $2.3 million (Q1 2026), $13.0 million (Q4 2025), and $2.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 1.00 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 788.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 12.58 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 455.70 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 1.24 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 621.10 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 494.00 Mn |
| 10 | IM Cannabis | 554,496.00 | -177,626.51 | 1.03 Mn | 2.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.26 Mn |
| Dec 31, 2025 | 13.05 Mn |
| Sep 30, 2025 | 2.24 Mn |
| Mar 31, 2025 | 2.29 Mn |
| Dec 31, 2024 | 11.42 Mn |
| Sep 30, 2024 | 3.01 Mn |
| Jun 30, 2024 | -13,891.67 |
| Mar 31, 2024 | 5.50 Mn |
| Dec 31, 2023 | 4.41 Mn |
| Sep 30, 2023 | 3.66 Mn |
| Jun 30, 2023 | 3.88 Mn |
| Mar 31, 2023 | 4.82 Mn |
| Dec 31, 2022 | 9.81 Mn |
| Sep 30, 2022 | 5.73 Mn |
| Jun 30, 2022 | 6.14 Mn |
| Mar 31, 2022 | 8.89 Mn |
| Dec 31, 2021 | 7.71 Mn |
| Sep 30, 2021 | 6.39 Mn |
| Jun 30, 2021 | 8.26 Mn |
| Mar 31, 2021 | 5.32 Mn |